Southern Acids (M) Berhad (KLSE:SAB)
Malaysia
· Delayed Price · Currency is MYR 3.410
+0.010 (0.29%)
At close: Aug 14, 2025
Southern Acids (M) Berhad Revenue
In the fiscal year ending March 31, 2025, Southern Acids (M) Berhad had annual revenue of 1.11B MYR with 20.19% growth. Southern Acids (M) Berhad had revenue of 263.75M in the quarter ending March 31, 2025, with 9.96% growth.
Revenue
1.11B
Revenue Growth
+20.19%
P/S Ratio
0.42
Revenue / Employee
657.17K
Employees
1,683
Market Cap
466.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.11B | 185.79M | 20.19% |
| Mar 31, 2024 | 920.22M | -186.52M | -16.85% |
| Mar 31, 2023 | 1.11B | -74.14M | -6.28% |
| Mar 31, 2022 | 1.18B | 434.96M | 58.31% |
| Mar 31, 2021 | 745.93M | 79.83M | 11.98% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Malayan Banking Berhad | 28.16B |
| Public Bank Berhad | 14.28B |
| Tenaga Nasional Berhad | 65.70B |
| CIMB Group Holdings Berhad | 20.86B |
| IHH Healthcare Berhad | 24.72B |
| Press Metal Aluminium Holdings Berhad | 15.19B |
| Celcomdigi Berhad | 12.79B |
| Hong Leong Bank Berhad | 6.67B |